U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 05-11-2024
- Paid Up Capital ₹ 0.20 M
as on 05-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -246.26%
(FY 2023)
- Ebitda -246.26%
(FY 2023)
- Net Worth -187.35%
(FY 2023)
- Total Assets -4.05%
(FY 2023)
About U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Uma Siddanki and Mallikarjun Siddanki serve as directors at the Company.
- CIN/LLPIN
U24304TG2020PTC143379
- Company No.
143379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Nizamabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Siddanki  | Director | 01-Sep-2020 | Current |
| Mallikarjun Siddanki | Director | 01-Sep-2020 | Current |
Financial Performance of U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals.
U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 246.26% decrease in profit. The company's net worth observed a substantial decline by a decrease of 187.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals?
Unlock access to U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Drone Space R&D Technology's Private LimitedActive 4 years 2 months
Uma Siddanki and Mallikarjun Siddanki are mutual person
- Uma Venu Vedha Engineering Software & Iot Projects Private LimitedActive 1 year 4 months
Uma Siddanki is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals?
U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U.M.R.Nano Nano Biotechnology Lifecare R&D Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
